Effects of SGLT2 inhibitors on cardiac function and health status in chronic heart failure: a systematic review and meta-analysis

被引:0
|
作者
Jiao Chen
Chunxia Jiang
Man Guo
Yan Zeng
Zongzhe Jiang
Dongmin Zhang
Mengqin Tu
Xiaozhen Tan
Pijun Yan
XunMei Xu
Yang Long
Yong Xu
机构
[1] the Affiliated Hospital of Southwest Medical University,Department of Endocrinology and Metabolism
[2] The Third Hospital of Mianyang,Department of Endocrinology
[3] Sichuan Mental Health Center,State Key Laboratory of Quality Research in Chinese Medicine
[4] Sichuan Clinical Research Center for Nephropathy,Faculty of Chinese Medicine
[5] Metabolic Vascular Disease Key Laboratory of Sichuan Province,undefined
[6] Macau University of Science and Technology,undefined
[7] Macau University of Science and Technology,undefined
来源
关键词
SGLT2 inhibitors; Cardiac function; Health status; Chronic Heart Failure; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis (vol 7, pg 3298, 2020)
    Butler, J.
    Usman, M. S.
    Khan, M. S.
    Greene, S. J.
    Friede, T.
    Vaduganathan, M.
    Filippatos, G.
    Coats, A. J. S.
    Anker, S. D.
    ESC HEART FAILURE, 2021, 8 (03): : 2362 - 2362
  • [22] Efficacy of sacubitril-valsartan and SGLT2 inhibitors in heart failure with reduced ejection fraction: A systematic review and meta-analysis
    Mo, Xingchun
    Lu, Ping
    Yang, Xiaojing
    CLINICAL CARDIOLOGY, 2023, 46 (10) : 1137 - 1145
  • [23] The Role of SGLT2 Inhibitors on Heart Failure Outcomes in Nondiabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Kommu, Sharath
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 83 (02) : 158 - 166
  • [24] SGLT2 inhibitors and cardiovascular outcomes in heart failure with mildly reduced and preserved ejection fraction: A systematic review and meta-analysis
    Banerjee, Mainak
    Pal, Rimesh
    Nair, Kirthana
    Mukhopadhyay, Satinath
    INDIAN HEART JOURNAL, 2023, 75 (02) : 122 - 127
  • [25] SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
    Neuen, Brendan L.
    Young, Tamara
    Heerspink, Hiddo J. L.
    Neal, Bruce
    Perkovic, Vlado
    Billot, Laurent
    Mahaffey, Kenneth W.
    Charytan, David M.
    Wheeler, David C.
    Arnott, Clare
    Bornpoint, Severine
    Levin, Adeera
    Jardine, Meg J.
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (11): : 845 - 854
  • [26] Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure
    Light, Peter E.
    EUROPEAN HEART JOURNAL, 2021, 42 (36) : 3739 - +
  • [27] SGLT2 Inhibitors in Patients with Heart Failure: A Model-Based Meta-Analysis
    Wang, Na
    Wu, Zhen
    Ren, Jianwei
    Zheng, Xin
    Han, Xiaohong
    CLINICAL PHARMACOKINETICS, 2024, : 1667 - 1678
  • [28] EFFECTS OF SGLT2 INHIBITORS ON LEFT VENTRICULAR MASS, VOLUME AND FUNCTION IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED STUDIES
    Romeo, Francisco
    Del Buono, Marco Giuseppe
    Damonte, Juan Ignacio
    Chiabrando, Juan Guido
    Aguilar-Gallardo, Jose S.
    Lorente-Ros, Marta
    Carbone, Salvatore
    Abbate, Antonio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 341 - 341
  • [29] Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis
    Gager, Gloria M. M.
    Gelbenegger, Georg
    Jilma, Bernd
    von Lewinski, Dirk
    Sourij, Harald
    Eyileten, Ceren
    Filipiak, Krzysztof
    Postula, Marek
    Siller-Matula, Jolanta M. M.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [30] SGLT2 Inhibitors in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials
    Ul Amin, Noor
    Sabir, Faiza
    Amin, Talal
    Sarfraz, Zouina
    Sarfraz, Azza
    Robles-Velasco, Karla
    Cherrez-Ojeda, Ivan
    HEALTHCARE, 2022, 10 (12)